| From: | Richard Cartun <Rcartun@harthosp.org> |
| To: | histonet@pathology.swmed.edu, Barb.Terrett@uhn.on.ca |
| Reply-To: | |
| Content-Type: | text/plain; charset=US-ASCII |
Novocastra Laboratories has a new mAb (clone MMM33) directed against a recombinant NS3 protein (NCL-HCV-NS3). RWC